Skip to main content
SpringerLink
Log in

TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy

  • Original Article
  • Published:
Tumor Biology

Abstract

Esophageal squamous cell carcinoma (ESCC) has a poor prognosis due to high lymphatic metastatic recurrence rates after Ivor Lewis esophagectomy. We sought to investigate the correlation between tumor necrosis factor alpha–induced protein 8 (TNFAIP8) expression and postoperative lymphatic recurrence in patients with pN0 ESCC. One hundred twenty-two patients with pN0 ESCC undergoing Ivor Lewis esophagectomy were enrolled in this study. TNFAIP8 overexpression was found in 73 (59.8 %) tumor specimens. The 3-year lymphatic metastatic recurrence rate among TNFAIP8-overexpressing patients was significantly higher than in TNFAIP8-negative patients (p = 0.003). Multivariate Cox regression identified TNFAIP8 overexpression as an independent risk factor for lymphatic recurrence (p = 0.048). TNFAIP8 messenger RNA (mRNA) levels were significantly higher in patients with lymphatic recurrence than in patients without tumor recurrence (p = 0.019). Stable silencing of TNFAIP8 expression in ESCC-derived cells (Eca109) reduced proliferation, motility, and invasion and induced apoptosis. In addition, transient silencing of TNFAIP8 expression decreased cell motility and invasion and increased apoptosis in a second ESCC-derived cell line (KYSE150). Taken together, these findings suggest that TNFAIP8 overexpression is a potential biomarker to identify pN0 ESCC patients at higher risk of lymphatic recurrence who may benefit from adjuvant therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

    Article  CAS  PubMed  Google Scholar 

  2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.

    Article  PubMed  Google Scholar 

  3. Collard JM, Otte JB, Fiasse R, Laterre PF, De Kock M, Longueville J, et al. Skeletonizing en bloc esophagectomy for cancer. Ann Surg. 2001;234:25–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Oezcelik A, Kaiser GM, Niebel W, Sleyman C, Treckmann JW, Sotiropoulos GC, et al. Ten-year survival of esophageal cancer after an en-bloc esophagectomy. J Surg Oncol. 2012;105:284–7.

    Article  PubMed  Google Scholar 

  5. Song Y, Wang Z, Liu X, Jiang W, Shi M. CCR7 and VEGF-C: molecular indicator of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy? Ann Surg Oncol. 2012;19:3606–12.

    Article  PubMed  Google Scholar 

  6. Hulscher JB, van Sandick JW, Tijssen JG, Obertop H, van Lanschot JJ. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg. 2000;191:143–8.

    Article  CAS  PubMed  Google Scholar 

  7. Stahl M, Budach W, Meyer HJ, Cervantes A. ESMO guidelines working group. Esophageal cancer: clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:v46–9.

    Article  PubMed  Google Scholar 

  8. National Comprehensive Cancer Network. NCCN clinical practice guideline in oncology (NCCN guideline): Esophageal and esophagogastric junction cancers. 2015. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site. Accessed 23 March 2015.

  9. Akhtar J, Wang Z, Jiang WP, Bi MM, Zhang ZP. Stathmin overexpression identifies high-risk of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients. J Gastroenterol Hepatol. 2013;29:944–50.

    Article  Google Scholar 

  10. Godfrey TE, Raja S, Finkelstein SD, Gooding WE, Kelly LA, Luketich JD. Prognostic value of quantitative reverse transcription polymerase chain reaction in lymph node-negative esophageal cancer patients. Clin Cancer Res. 2001;7:4041–8.

    CAS  PubMed  Google Scholar 

  11. Li SH, Wang Z, Liu XY. Metastasis-associated protein 1 (MTA1) overexpression is closely associated with shorter disease-free interval after complete resection of histologically node-negative esophageal cancer. World J Sug. 2009;33:1876–81.

    Article  Google Scholar 

  12. Patel S, Wang FH, Whiteside TL, Kasid U. Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol. 1997;33:197–203.

    Article  CAS  PubMed  Google Scholar 

  13. Kumar D, Whiteside TL, Kasid U. Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein. J Biol Chem. 2000;275:2973–8.

    Article  CAS  PubMed  Google Scholar 

  14. Dong QZ, Zhao Y, Liu Y, Wang Y, Zhang PX, Jiang GY, et al. Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer. Cancer Sci. 2010;101:1562–9.

    Article  CAS  PubMed  Google Scholar 

  15. Kumar D, Gokhale P, Broustas C, Chakravarty D, Ahmad I, Kasid U. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene. 2004;23:612–6.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang C, Chakravarty D, Sakabe I, Mewani RR, Boudreau HE, Kumar D, et al. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther. 2006;13:947–55.

    Article  CAS  PubMed  Google Scholar 

  17. Liu T, Gao H, Yang M, Zhao T, Liu Y, Lou G. Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer. Tumor Biol. 2014;35:5805–14.

    Article  CAS  Google Scholar 

  18. Miao Z, Zhao T, Wang Z, Xu Y, Song Y, Wu J, et al. SCC-S2 is overexpressed in colon cancers and regulates cell proliferation. Tumor Biol. 2012;33:2099–106.

    Article  CAS  Google Scholar 

  19. Liu T, Gao H, Chen X, Lou G, Gu L, Yang M, et al. TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer. Br J Cancer. 2013;109:1685–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Yang M, Zhao Q, Wang X, Liu T, Yao G, Lou C, et al. TNFAIP8 overexpression is associated with lymph node metastasis and poor prognosis in intestinal-type gastric adenocarcinoma. Histopathology. 2014;65:517–26.

    Article  PubMed  Google Scholar 

  21. Zhang C, Kallakury BV, Ross JS, Mewani RR, Sheehan CE, Sakabe I, et al. The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence. Int J Cancer. 2013;133:31–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hadisaputri YE, Miyazaki T, Suzuki S, Yokobori T, Kobayashi T, Tanaka N, et al. TNFAIP8 overexpression: clinical relevance to esophageal squamous cell carcinoma. Ann Surg Oncol. 2012;3:S589–96.

    Article  Google Scholar 

  23. Rice TW, Rusch VW, Ishwaran H, Blackstone EH. Worldwide esophageal cancer collaboration. Cancer of the esophagus and esophagogastric junction: data-driven staging for the Seventh Edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer. 2010;116:3763–73.

    Article  PubMed  Google Scholar 

  24. Akhtar J, Wang Z, Zhang ZP, Bi MM. Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo. J Transl Med. 2013;11:212.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Law S, Wong J. Two-field dissection is enough for esophageal cancer. Dis Esophagus. 2001;14:98–103.

    Article  CAS  PubMed  Google Scholar 

  26. Chen G, Wang Z, Liu XY, Zhang MY, Liu FY. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus. Eur J Cardiothorac. 2009;35:1–7.

    Article  Google Scholar 

  27. Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205–11.

    Article  PubMed  Google Scholar 

  28. Hou X, Wei JC, Fu JH, Wang X, Zhang LJ, Lin P, et al. Proposed modification of the seventh American joint committee on cancer staging system for esophageal squamous cell carcinoma in Chinese patients. Ann Surg Oncol. 2014;21:337–42.

    Article  PubMed  Google Scholar 

  29. Wang ZX, Mao T, Guo XF, Fang WT. Multimodality management of squamous cell carcinoma of thoracic esophagus. Zhonghua Wei Chang Wai Ke Za Zhi. 2013;16:815–8.

    PubMed  Google Scholar 

  30. You Z, Ouyang H, Lopatin D, Polver PJ, Wang CY. Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem. 2001;276:26398–404.

    Article  CAS  PubMed  Google Scholar 

  31. Fish RJ, Kruithof EK. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors. BMC Mol Biol. 2004;5:9.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Chen H, Wang Z, Yang Z, Shang B, Liu X, Chen G. Prospective study of adjuvant radiotherapy on preventing lymph node metastasis after Ivor-Lewis esophagectomy in esophageal cancer. Ann Surg Oncol. 2013;20:2721–6.

    Article  PubMed  Google Scholar 

  33. Zhang HG, Hyde K, Page GP, Brand JP, Zhou J, Yu S, et al. Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis. Arthritis Rheum. 2004;50:420–31.

    Article  CAS  PubMed  Google Scholar 

  34. Xu WW, Li B, Lam AK, Tsao SW, Law SY, Chan KW, et al. Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy. Oncotarget. 2015;6:1790–805.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank the Department of Pathology, Provincial Hospital Affiliated to Shandong University, for specimen collection and staining evaluation. This work is supported by grants from the National Natural Science Foundation of China (No. 81172161), Jinan Science and Technology Plan (201202041). Dr. Meltzer is the Myerberg/Hendrix Professor of Gastroenterology and an American Cancer Society Clinical Research Professor.

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, 324 Jingwu Road, Jinan, 250021, Shandong, China

    Zhenguo Sun, Xiangyan Liu, Yang Jia & Zhou Wang

  2. Division of Gastroenterology, Department of Medicine and Oncology and Sidney Kimmel Comprehensive Cancer Centre, The Johns Hopkins University School of Medicine, 1503 East Jefferson Street, Room 112, Baltimore, MD, 21287, USA

    Zhenguo Sun, Jee Hoon Song, Yulan Cheng & Stephen J. Meltzer

  3. Department of Pathology, Provincial Hospital Affiliated to Shandong University, 324 Jingwu Road, Jinan, 250021, Shandong, China

    Yu Liu

Authors
  1. Zhenguo Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiangyan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jee Hoon Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yulan Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yang Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stephen J. Meltzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhou Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Stephen J. Meltzer or Zhou Wang.

Ethics declarations

Conflict of interests

None

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 565 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, Z., Liu, X., Song, J.H. et al. TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy. Tumor Biol. 37, 10923–10934 (2016). https://doi.org/10.1007/s13277-016-4978-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-016-4978-1

Keywords

Search

Navigation